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OBJECTIVE — The aim of this study is to investigate the intake of zinc in relation to risk of
type 2 diabetes in U.S. women.
RESEARCH DESIGN AND METHODS — Dietary intakes of zinc and other nutrients
were assessed and updated using a validated food frequency questionnaire from 1980 to 2002
among 82,297 women who were aged 33–60 years at baseline in 1980 and followed up to 2004
in the Nurses’ Health Study.
RESULTS — During the 24 years of follow-up, 6,030 incident cases of type 2 diabetes were
ascertained.Afteradjustmentoflifestyleanddietaryriskfactors,therelativerisks(RRs)(95%CI)
of type 2 diabetes comparing the highest with the lowest quintiles were 0.90 (0.82–0.99)
(Ptrend0.04)fortotalzincintakeand0.92(0.84–1.00)(Ptrend0.009)fordietaryzincintake
fromfoodsources,respectively.Wefurtherfoundaninverseassociationfordietaryzinctoheme
iron ratio. After multivariate adjustment of covariates, the RRs (95% CI) across quintiles of this
ratio were 1.0 (reference), 0.93 (0.86–1.01), 0.86 (0.79–0.94), 0.82 (0.75–0.90), and 0.72
(0.66–0.80), respectively (Ptrend  0.0001).
CONCLUSIONS — Higher zinc intake may be associated with a slightly lower risk of type 2
diabetes in women. More studies are warranted to conﬁrm this association and to explore
potential mechanisms.
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Z
inc is an essential trace element that
exists in all cells and is required by
thousands of proteins for catalytic,
structural, or transcriptional functions.
Since the 1930s when zinc was ﬁrst dem-
onstrated to be an integral element of the
insulin crystalline structure (1), many
studieshavebeenconductedtoshedlight
on the relationship between zinc and in-
sulin action. Animal studies have shown
that zinc is able to not only stabilize and
preventthedegradationofinsulinhexam-
ers(2),astorageformofinsulinin-cells,
but also improve the binding of insulin to
liver receptors and inhibit the degrada-
tion by live plasma membranes (3). In ro-
dent models, zinc supplementation
attenuatedhyperglycemiaandhyperinsu-
linemia in ob/ob and db/db mice (4,5).
Interestingly, oral or intraperitoneal ad-
ministration of certain zinc complexes
showed insulinomimetic effects in rodent
models,includingstimulatinglipogenesis
and attenuating hyperglycemia (6,7). In
addition, there is increasing evidence
supporting the role of zinc as an anti-
oxidant that could protect insulin and
cells from being attacked by free radicals
(8).
Despite the evidence from animal
studies that zinc intake may have protec-
tive effects against type 2 diabetes, few
studies in humans have been conducted
toexaminethisrelationship.InobeseBra-
zilian women, 4 weeks of zinc supple-
mentation (30 mg/day) signiﬁcantly
improved insulin sensitivity (9). In a
cross-sectional analysis, higher dietary
zinc intake was associated with a lower
prevalenceofdiabetesandmetabolicsyn-
drome in an Indian population (10).
However, the hypothesis that dietary zinc
intake is associated with a reduced risk of
type 2 diabetes has not been examined in
aprospectivestudy.Also,itwouldbeuse-
fultoexaminetheassociationsforsupple-
mental zinc and zinc from food sources
separatelybecausetheformerismorebio-
available than the latter (11). In addition,
minerals with similar physical or chemi-
cal properties, such as iron and zinc,
would compete with each other biologi-
cally (12). Several human studies already
demonstrated that both inorganic iron
and heme iron can inhibit the absorption
ofzinc(13).Whetherironintakesmodify
the association of zinc on risk of type 2
diabetes has not been examined in epide-
miologicalstudies.Therefore,weusedthe
prospective data with repeated measure-
ments of dietary intake from the Nurses’
Health Study to evaluate the long-term
zinc intake in relation to risk of type 2
diabetesandtoexaminethepotentialiron
and zinc interactions.
RESEARCH DESIGN AND
METHODS— The Nurses’ Health
Study is an ongoing prospective cohort
studyconductedinU.S.registeredfemale
nurses.Thestudydesignwasdescribedin
detail elsewhere (14). Brieﬂy, a list of
names and addresses of 238,026 regis-
tered nurses who lived in 1 of 11 states
and fulﬁlled the eligibility criteria (mar-
ried female) were obtained in 1972 from
the American Nurses’ Association. Of
these eligible women, 65,613 (27.6%)
were either unreachable by mail or al-
ready deceased. Of the remaining
172,413 women, 121,701 (70.6%) com-
pletedbaselinequestionnairesabouttheir
lifestyle and medical history. Follow-up
questionnaires were sent to participating
nurses biennially to update the informa-
tion of lifestyle risk factors and disease
occurrence. Up to 2004, the follow-up
rate was 95% in the Nurses’ Health
Study.
For the current analysis, we used
1980 as the study baseline when the ﬁrst
food frequency questionnaire (FFQ) was
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1) a history of diabetes, cancer (except
nonmelanoma skin cancer), or cardiovas-
cular disease at baseline; 2) 10 items of
the 1980 FFQ were missing; and/or 3) to-
tal energy intake 500 kcal/day or
3,500 kcal/day. We excluded partici-
pantswithmajorchronicdiseasesatbase-
line based on considerations that these
participants may have changed their diet
because of the diagnosis of chronic dis-
eases. In addition, the study hypothesis
was to examine zinc and diabetes rela-
tionship among relatively healthy partici-
pants rather than people with these
chronic diseases; the association may be
different between people with and with-
out chronic diseases. After these exclu-
sions, 82,297 participants were available
for analysis. The study protocol was ap-
proved by the institutional review boards
of the Brigham and Women’s Hospital
and Harvard School of Public Health.
Dietary assessment
In 1980, a 61-item FFQ was sent to par-
ticipants to inquire about their dietary in-
takes. Similarly, expanded FFQs were
administered every 2–4 years since 1980.
The FFQs used in the Nurses’ Health
Study were designed to inquire about
food consumption in the previous year.
For each food item, a standard portion
size was speciﬁed and the participants
were asked how often, on average, they
consumedfoodsofthatspeciﬁedamount.
There were nine possible coding re-
sponses, ranging from “never or less than
oncepermonth”to“sixormoretimesper
day.” Multivitamin and zinc supplement
use were assessed in the 1980 question-
naire and in all biennial follow-up ques-
tionnaires. Zinc intake from food sources
was calculated by multiplying the fre-
quency of consumption of each food by
the zinc composition in the speciﬁed
amount of that food and then summing
up the zinc intake from each food item.
The food composition database was pri-
marily based on the U.S. Department of
Agriculture sources. When estimating the
total zinc intake, supplementation use
was taken into account as well. The FFQs
have been validated against multiple food
records and showed reasonable correla-
tionsformostnutrients(15).ThePearson
correlation coefﬁcient between the FFQ
and two 1-week diet record assessments
of zinc intake was 0.67 in a validation
study among 127 health professionals
(16). In the current analysis, we adjusted
nutrient intakes, except for alcohol in-
take, for total energy intake using the re-
sidual method (15).
Assessment of type 2 diabetes
Women who reported a diagnosis of type
2 diabetes in the biennial follow-up ques-
tionnairesweresentsupplementaryques-
tionnaires inquiring about symptoms,
diagnostic tests, and treatment for the
purpose of conﬁrmation. Consistent with
the criteria of the National Diabetes Data
Group, diagnosed cases required 1) an el-
evated glucose concentration (fasting
plasma glucose 7.8 mmol/l, random
plasma glucose 11.1 mmol/l, or plasma
glucose 11.1 mmol/l after an oral glu-
coseload)andatleastonesymptomrelated
to diabetes (excessive thirst, polyuria,
weight loss, or hunger); 2) no symptoms
but elevated glucose concentrations on two
occasions; and 3) treatment with insulin or
oral hypoglycemic medication. For cases of
type 2 diabetes identiﬁed after 1998, the
cutoff point used for fasting plasma glucose
concentrations was lowered to 7.0 mmol/l,
according to the American Diabetes Associ-
ation criteria.
The self-report of diagnosis of type 2
diabeteshasbeenproventobeaccuratein
avalidationstudy.Ofarandomsampleof
62 nurses reporting type 2 diabetes, 61
(98%) were conﬁrmed after their medical
records were reviewed by an endocrinol-
ogist blinded to the supplementary ques-
tionnaire information. Women with the
diagnosis of type 1 diabetes were ex-
cluded from the current analysis. Deaths
were identiﬁed by reports from next of
kin,postalauthorities,orbysearchingthe
National Death Index. At least 98% of
deaths among the Nurses’ Health Study
participants were identiﬁed.
Statistical analysis
Each participant’s person-years of fol-
low-up were counted from the date of re-
turning 1980 FFQ to June 2004, the date
of death, or the date of diagnosis of type 2
diabetes, whichever came ﬁrst. We used
Cox proportional hazard regressions to
estimate the relative risks (RRs) for total
and dietary zinc intake in relation to the
riskoftype2diabetes.Tocontrolasﬁnely
as possible for confounding by age and
calendar time, we stratiﬁed the analysis
jointly by age in months at start of fol-
low-up and calendar year of the current
questionnairecycle.Thetimescaleforthe
analysis was then measured as months
sincethestartofthecurrentquestionnaire
cycle. Women were categorized into
quintiles according to the intake of total
or dietary zinc. To examine the propor-
tional hazard assumption of Cox regres-
sions, we constructed interaction terms
between dietary zinc intake and calendar
year and used likelihood ratio tests to as-
sess the signiﬁcance of these interaction
terms. Likelihood ratio tests are based on
the difference of 2 log likelihood of
models with and without interaction
terms and follow the 
2 distribution with
the degree of freedom equal to the num-
ber of parameters of interaction terms. P
values for the interaction terms were 0.48
for total zinc analysis and 0.30 for dietary
zinc analysis, indicating that the pro-
portional hazard assumption was not
violated.
To minimize the impact of random
measurementerrorsofdietaryassessment
and to better represent long-term diet, we
calculated the cumulative averages of nu-
trient intakes from baseline to the censor-
ing events. These cumulative averages
were treated as time-varying covariates.
To avoid systematic errors in dietary as-
sessment due to the biased recall after oc-
currence of chronic diseases that may
change usual dietary habit, we stopped
updatingdietwhenaparticipantreported
a diagnosis of hypertension, hypercholes-
terolemia, cardiovascular disease, peptic
ulcer, or cancer and then carried forward
thecumulativeaveragesofdietaryintakes
before the occurrence of these diseases to
represent long-term diet for later follow-
up (17).
In the multivariate analysis, we ad-
justed for age, BMI, family history of dia-
betes (among ﬁrst-degree relatives),
smoking, alcohol intake, menopausal sta-
tus, postmenopausal hormone use, mul-
tivitamin use, physical activity, total
energy intake, glycemic load, polyunsat-
urated-to-saturated fat intake ratio, and
intakes of red meat, heme iron, whole
grains,transfat,magnesium,andcaffeine.
Likelihood ratio tests were used to evalu-
ate the signiﬁcance of potential interac-
tions between zinc and iron intakes. We
further examined the associations for
zinc–to–total iron and zinc–to–heme
iron ratios.
Tests for trends were conducted by
assigning the median value to each quin-
tile and modeling this value as a continu-
ous variable. All P values were two sided.
Ninety-ﬁve percent CIs were calculated
for relative risks. Data were analyzed with
the Statistical Analysis Systems software
package, version 9.1 (SAS Institute, Cary,
NC).
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follow-up, we identiﬁed and conﬁrmed
6,030 cases of incident type 2 diabetes.
Women in the higher quintiles of either
total or dietary zinc intake were slightly
older and less likely to have a history of
hypertension and hypercholesterolemia
(Table 1). Higher zinc intake was also as-
sociated with higher intakes of cereal ﬁ-
ber, caffeine, chicken, and dairy products
and lower intakes of alcohol, glycemic
load, red meat, and polyunsaturated and
trans fat. At baseline, on average, 6.3% of
the women reported use of supplements
that contained zinc (including both mul-
tivitamin and zinc-speciﬁc supplement
use). In 2004, the proportion of use of
zinc-containingsupplementsincreasedto
48.6%, mostly due to the increased use of
multivitamins that contain zinc. Women
in the higher quintiles of dietary zinc in-
takewerealsomorelikelytousezincsup-
plements than did those in the lower
quintiles.
In age-adjusted analysis, intake of to-
tal zinc, but not dietary zinc from food
sources, was signiﬁcantly associated with
a lower risk of type 2 diabetes (Table 2).
After adjustment for nondietary risk fac-
tors, including age, BMI, smoking, and
other covariates, highest quintiles of both
total and dietary zinc intake were signiﬁ-
cantly associated with an 20% lower
risk of type 2 diabetes. After further ad-
justment for dietary risk factors, the asso-
ciations were attenuated but remained
statistically signiﬁcant. When we exam-
ined the associations for dietary zinc in-
take, we further adjusted for the zinc
intakesfromsupplements.Incomparison
with women in the lowest quintile,
women in the highest quintiles of total
and dietary zinc intakes had a 10% (95%
CI1–8)(Ptrend0.04)andan8%(0–16)
(Ptrend  0.009) lower risk of type 2 dia-
betes, respectively. Zinc intake from sup-
plement use was associated with the risk
of type 2 diabetes only among women
with the lowest dietary zinc intake levels.
Among women in the lowest tertile for
dietary zinc intake, the RRs (95% CI) for
the tertiles of supplemental zinc intake
were 1.0 (reference), 1.02 (0.87–1.21),
and 0.86 (0.74–0.99), respectively
(Ptrend  0.009). In contrast, among
women in the higher tertiles of dietary
zinc intake, supplemental zinc intake was
not associated with the risk of type 2 dia-
betes. The corresponding RRs (95% CI)
for supplemental zinc intake tertiles were
1.0 (reference), 1.14 (0.98–1.33), and
1.05(0.92–1.19)(Ptrend0.78).Similarly,
dietary zinc intake was more strongly asso-
ciated with a lower risk of type 2 diabetes
among those with low zinc intakes from
supplements. The RRs (95% CI) for the
highest tertile of dietary zinc intake were
0.84 (0.75–0.95) (Ptrend  0.007) or 1.0
(0.87–1.16) (Ptrend 0.98) among women
in the lowest or highest tertile of supple-
mental zinc intake levels, respectively.
Although we did not ﬁnd signiﬁcant
interactions between zinc and heme iron
intakes (Pinteraction  0.13 for total zinc
and 0.07 for dietary zinc, respectively),
zinc–to–heme iron ratios, especially di-
etary zinc–to–heme iron ratio, were sig-
niﬁcantly associated with a lower risk of
type 2 diabetes after multivariate adjust-
ment for covariates (Table 3). Because
these ratios are signiﬁcantly correlated
with heme iron intake (correlation coefﬁ-
cients  0.30 for total zinc–to–heme
iron ratio and 0.50 for dietary zinc–to–
heme iron ratio, respectively), associa-
tions of these ratios might be strongly
inﬂuenced by the positive association be-
tween heme iron intake and risk of type 2
diabetes. To examine the robustness of
these associations, we conducted a sensi-
tivity analysis with further adjustment for
heme iron intake. The association for di-
etary zinc–to–heme iron ratio was atten-
uated but remained signiﬁcant after such
adjustment. The RR for highest quintile
versuslowestquintilewas0.75(95%CI
0.66–0.85) (Ptrend  0.0001). In con-
trast, the association for total zinc–to–
heme iron ratio was somewhat weaker.
The RR for highest quintile versus low-
est quintile was 0.87 (0.78–0.96)
(Ptrend  0.05). We did not ﬁnd any
signiﬁcant interaction between zinc and
total iron or for zinc/total iron ratios.
We conducted several sensitivity
analyses to examine the robustness of the
Table 1—Age-standardized characteristics by quintile (Q) of total and dietary zinc intake in
the Nurses’ Health Study at baseline
Total zinc intake Dietary zinc intake
Q1 Q3 Q5 Q1 Q3 Q5
Intake of zinc (mg/day) 2.7 5.4 16.2 2.7 5.0 10.7
Demography
Age (year) 45.8 46.1 46.1 45.8 46.0 46.1
Physical activity (MET/hr)* 3.2 3.4 3.3 3.2 3.4 3.4
BMI (kg/m
2) 23.9 24.3 24.1 23.9 24.3 24.1
Current smoker (%) 32.9 26.3 30.8 32.8 26.3 30.8
Postmenopausal (%) 30.9 30.8 30.6 30.9 30.8 30.8
Postmenopausal hormone use (%)† 30.3 31.3 31.6 31.1 31.0 29.6
Hypertension (%) 15.2 14.5 13.8 15.3 14.8 13.8
High cholesterol (%) 5.0 4.9 4.2 5.0 5.0 4.1
Family history of diabetes (%) 24.0 24.3 24.1 24.1 24.7 23.1
Diet
Trans fat (% of total calories) 2.6 2.2 2.0 2.6 2.3 1.9
Saturated fat (% of total calories) 15.9 15.1 16.7 15.9 15.1 16.5
Polyunsaturated fat (% of total calories) 5.8 5.3 4.8 5.8 5.4 4.7
Alcohol (g/day) 7.5 6.2 6.4 7.5 6.3 6.3
Cereal ﬁber (mg/day) 1.9 2.6 2.8 1.9 2.5 2.8
Magnesium (mg/day) 257.5 304.0 298.4 258.0 300.8 301.1
Caffeine (mg/day) 363.7 406.9 415.7 362.9 402.9 420.7
Glycemic load 86.5 86.1 83.8 86.4 86.4 83.8
Heme iron (mg/day) 1.8 1.5 1.4 1.9 1.5 1.4
Red meat (servings/day) 1.7 1.3 1.3 1.7 1.4 1.2
Fish (servings/week) 0.9 1.3 1.1 0.9 1.2 1.2
Chicken (servings/week) 1.2 1.9 1.9 1.2 1.9 2.0
Dairy products (servings/day) 1.0 2.0 2.0 1.0 1.9 2.1
Fruits and vegetables (servings/day) 3.5 4.2 3.9 3.6 4.2 3.9
Whole grains (g/day)‡ 9.0 12.0 11.7 9.0 12.0 11.6
Multivitamin supplement user (%) 24.6 32.9 46.8 27.9 34.9 36.3
Zinc supplement user (%) 0.4 2.5 23.1 4.8 6.7 7.1
*MET/hr denotes metabolic equivalent hours. †Among postmenopausal women. ‡Whole-grain intake data
were based on 1984 FFQ assessment.
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ciations between zinc intake and type 2
diabetes risk were somewhat weaker
when we 1) used baseline diet only, 2)
censored participants after they devel-
oped chronic diseases, or 3) continued
updatingdietafterparticipantsdeveloped
chronic diseases.
CONCLUSIONS— In this prospec-
tive cohort study, we found a modest in-
verse association between zinc intake and
riskoftype2diabetesinU.S.womenafter
adjustment of established and potential
confounders. In addition, a higher zinc–
to–heme iron ratio was associated with a
signiﬁcantly lower risk of type 2 diabetes.
The close relationship between zinc
and insulin action was ﬁrst documented
byScott(1)inearly1930s,whenzincwas
found to be an integral component of
crystallineinsulin.Overtheyears,studies
have shown that zinc ions play important
roles in the biosynthesis, storage, and ac-
tion of insulin (2). Interestingly, certain
Table 2—RRs and 95% CIs for type 2 diabetes during 24 years of follow-up by quintile (Q) of zinc intake in the Nurses’ Health Study*
Intake Q1 Q2 Q3 Q4 Q5 Ptrend†
Total zinc (mg/day) 4.9 (6.0) 7.7 (6.0–8.6) 9.4 (8.7–10.3) 11.4 (10.4–13.3) 18.0 (13.3) —
n of diabetes onsets 1,208 1,256 1,258 1,202 1,106 —
Person-years 335,665 365,448 410,141 361,592 367,857 —
Age adjusted 1.0 0.96 (0.89–1.04) 0.91 (0.84–0.99) 0.92 (0.85–1.00) 0.83 (0.77–0.90) 0.0001
Age and nondietary factors
adjusted‡ 1.0 0.93 (0.86–1.01) 0.83 (0.77–0.90) 0.86 (0.79–0.93) 0.82 (0.75–0.89) 0.0001
Age, nondietary, and dietary
factors adjusted§ 1.0 0.97 (0.90–1.06) 0.88 (0.81–0.96) 0.92 (0.84–1.00) 0.90 (0.82–0.99) 0.04
Dietary zinc (mg/day) 5.0 (6.0) 7.3 (6.0–8.0) 8.7 (8.1–9.3) 9.9 (9.4–10.6) 11.6 (10.6) —
n of diabetes onsets 1,179 1,228 1,140 1,240 1,243 —
Person-years 340,219 376,260 363,931 387,481 372,811 —
Age adjusted 1.0 0.95 (0.88–1.03) 0.89 (0.82–0.97) 0.95 (0.88–1.03) 1.00 (0.92–1.08) 0.08
Age and nondietary factors
adjusted‡ 1.0 0.95 (0.88–1.03) 0.85 (0.78–0.92) 0.83 (0.77–0.90) 0.83 (0.77–0.90) 0.0001
Age, nondietary, and dietary
factors adjusted§¶ 1.0 1.01 (0.93–1.10) 0.92 (0.84–1.00) 0.91 (0.83–0.99) 0.92 (0.84–1.00) 0.009
*For the intake level at each quintile, values were expressed as median (range). †P values for trends were conducted by assigning the median value to each quintile
and modeling this value as a continuous variable. ‡Nondietary factors included BMI (21, 21–22.9, 23–24.9, 25–26.9, 27.0–29.9, 30.0–32.9, 33–34.9, 35–39.9,
or40kg/m
2),familyhistoryofdiabetes(yes,no),smokingstatus(never,past,currentwithcigaretteuseof1–14,15–24,or25perday,ormissing),alcoholintake
(0, 0.1–4.9, 5.0–14.9, or 15.0 g/day), menopausal status (yes, no), postmenopausal hormone use (never, past, or current user), multivitamin use (yes, no), and
physical activity (3, 3–8, 9–17, 18–27, or 27 MET/week). §Dietary factors included total energy (kcal) and quintiles of glycemic load, polyunsaturated-to-
saturated fat ratio, and intakes of red meat, heme iron, whole grains, trans fat, magnesium, and caffeine. ¶Zinc intake from supplement use (in tertiles) was further
adjusted when modeling the associations for dietary zinc intake.
Table 3—RRs and 95% CIs for type 2 diabetes during 24 years of follow-up by quintile (Q) of zinc–to–heme iron ratio in the Nurses’ Health
Study*
Q1 Q2 Q3 Q4 Q5 Ptrend†
Total zinc to heme iron 2.9 (5.0) 6.4 (5.0–7.5) 8.6 (7.6–9.9) 11.5 (10.0–14.3) 20.6 (14.3) —
n of diabetes onsets 1,430 1,333 1,237 1,050 980 —
Person-years 338,715 366,796 379,268 377,332 378,035 —
Age adjusted 1.0 0.85 (0.79–0.92) 0.77 (0.71–0.83) 0.64 (0.59–0.69) 0.59 (0.54–0.64) 0.0001
Age and nondietary factors
adjusted‡ 1.0 0.85 (0.79–0.92) 0.82 (0.75–0.88) 0.75 (0.69–0.81) 0.74 (0.68–0.81) 0.0001
Age, nondietary, and dietary
factors adjusted‡ 1.0 0.87 (0.80–0.94) 0.85 (0.78–0.92) 0.79 (0.72–0.86) 0.81 (0.74–0.89) 0.0002
Dietary zinc to heme iron 2.9 (4.7) 6.1 (4.7–7.0) 7.8 (7.1–8.7) 9.7 (8.8–10.9) 13.1 (10.9) —
n of diabetes onsets 1,403 1,410 1,252 1,114 851 —
Person-years 337,433 367,450 374,909 381,295 379,060 —
Age adjusted 1.0 0.92 (0.85–0.99) 0.79 (0.74–0.86) 0.69 (0.64–0.75) 0.52 (0.48–0.57) 0.0001
Age and nondietary factors
adjusted‡ 1.0 0.91 (0.85–0.98) 0.83 (0.77–0.90) 0.78 (0.72–0.85) 0.67 (0.61–0.73) 0.0001
Age, nondietary, and dietary
factors adjusted‡§ 1.0 0.93 (0.86–1.01) 0.86 (0.79–0.94) 0.82 (0.75–0.90) 0.72 (0.66–0.80) 0.0001
*Value of the ratios were expressed as median (range). †P values for trends were conducted by assigning the median value to each quintile and modeling this value
as a continuous variable. ‡The variables included in the multivariable models can be found in the footnotes to Table 2, except heme iron intake. §Zinc intake from
supplement use was further adjusted when modeling the associations for dietary zinc–to–heme iron ratio.
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mimeticeffects,includingattenuatinghy-
perglycemia and increasing lipogenesis,
when these complexes were orally or in-
traperitoneally administrated to mice
(6,7). Studies on mechanisms underlying
the effects of zinc on insulin signaling are
limited. But current evidence suggested
that enhancement of tyrosine kinase
phosphorylation in insulin signal trans-
duction (18) and improved binding of in-
sulin to its receptor may be involved (3).
Another line of evidence indicated that
zinc could act as an antioxidant as well.
Zinc may protect insulin and -cells from
being attacked by free radicals by playing
a structural role of antioxidant enzymes,
such as copper, zinc, and superoxide dis-
mutase (CuZnSOD) (19,20), by compet-
ing with redox-active transitional metals,
such as iron (19,20), or by stimulating
expressionofmetallothionein(21),afree-
radical scavenger (22).
Despitethisevidence,humandatare-
garding this association are sparse (9,10).
To our knowledge, the current study pro-
vided the ﬁrst prospective epidemiologic
data suggesting an inverse association be-
tween zinc intake and risk of type 2 dia-
betes. In the U.S. diet, the primary
sourcesofzincincludecereals,meats,and
dairy products, as well as supplements
(23). In the current analysis, the magni-
tude of associations for the highest quin-
tile was similar for total and dietary zinc
intake despite the fact that the median
level of the former was nearly twice as
highasthelatter,indicatingthatzincsup-
plementation may not further decrease
the risk of type 2 diabetes in people with
high dietary zinc intake. Indeed, in the
current analysis, zinc intake from supple-
ments was associated with a lower risk of
type 2 diabetes only among those who
had low levels of dietary zinc intake and
viceversa.Theaverageintakelevelsinour
participants have reached the recom-
mendeddietaryallowance,whichis8mg/
dayforwomen(11).Thebioavailabilityof
zinc is higher for zinc supplements than
for zinc from foods, but when dietary in-
take levels are adequate, additional zinc
intake from supplements may not confer
further beneﬁts (11).
In the current study, a higher dietary
zinc–to–heme iron ratio was signiﬁcantly
associated with a lower diabetes risk. Al-
though it is clear that nonheme iron can
inhibit inorganic zinc absorption, few
studies have examined the interplay be-
tween heme iron and organic zinc in
foods (13). It is possible that heme iron,
for which absorption is through separate
pathways and is less regulated than inor-
ganic nonheme iron (24), may inhibit di-
etary zinc absorption but has weaker
effects on highly bioavailable supplemen-
tal zinc absorption. Another possible
mechanism for zinc-heme iron interac-
tion is that zinc may compete with iron
ions for chelation by the organic ligand
cysteine and thus inhibit the production
of hydroxyl radicals in human body (20).
Heme iron contributes to high body iron
stores, which has been demonstrated to
be a risk factor for type 2 diabetes (25).
One of the strengths of this prospec-
tive study design was that dietary data
were collected before the occurrence of
disease so that disease status could not
inﬂuence the self-report of diet. We fur-
ther stopped updating the dietary data af-
ter report of chronic diseases that might
changethedietoftheparticipants.Bycal-
culatingthecumulativeaverageofdietary
intakes, we minimized the measurement
errors caused by change of diet over time
(17).Severallimitationsareworthdiscus-
sion as well. Although we adjusted for a
multitude of established and potential
lifestyleanddietaryconfounders,wecan-
not entirely exclude the possibility that
residualconfoundingmayexplaintheob-
served associations. In addition, despite
thattheFFQswerevalidatedagainstmul-
tiple diet records, assessment of zinc in-
take was still inevitably subject to some
measurement error. However, since the
dietary intakes of zinc were assessed pro-
spectively, such measurement error is
more likely to be random and thus atten-
uate the true associations. Because the
vastmajorityofparticipantsinthecurrent
studywerewhitenurses,itisimportantto
examine whether the results can be gen-
eralized to women of other ethnicities or
professions in future studies. Finally, we
observed these signiﬁcant associations
onlyafterusingcumulativeaverageofdiet
and stopping diet updates after partici-
pants developed chronic diseases. Our
previousanalyseshaveshownthattheuse
of cumulative averages yielded stronger
estimates than the use of baseline diet
only or simply updated diet (17), proba-
bly because the cumulative averages re-
duce measurement errors and also reﬂect
long-term diet.
In summary, the current study pro-
vidednovelevidencethatzincintakemay
be associated with a lower risk of type 2
diabetes in U.S. women. Our results also
suggest that a diet with high zinc–to–
heme iron ratio is signiﬁcantly associated
with lower risk of type 2 diabetes. These
ﬁndings are considered preliminary, and,
thus,furtherstudiesarewarrantedtocon-
ﬁrm these ﬁndings.
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